Insurance for QNatal® Advanced

A woman checks information on her phone
QNatal® Advanced noninvasive prenatal screening is covered by many insurance plans. When covered, 60% of patients pay $0. Learn more about the financial options available to your patients.

Smart codes for smart screening

Female doctors talking

Patients coming to your office for cervical cancer screening may also be at risk for sexually transmitted infections (STIs).

Quest Smart Codes make it easy to order both the cervical cancer screening and STI tests that cover your patients’ needs.

Smart Codes follow current screening guidelines (ACOG, CDC).

Protect their health

Group of young people against wall

Female patients under the age of 25 are most at risk for chlamydia and gonorrhea. Implement a universal screening program and protect their reproductive health with help from It’s Best to Test

Accurate screening for HPV infections as part of co-testing for cervical cancer screening

The Aptima® HPV mRNA assay identifies the presence and activity of high-risk HPV infections.

The power of next-generation sequencing

The_power_of_next-generation_sequencing_Thumbnail

QHerit® combines next-generation sequencing (NGS) with a growing genomics database and includes tests recommended by guidelines and advocacy groups.

 

Co-testing recommended for women 30-65

Female doctor showing results to female patient

Co-testing solutions with Pap and HPV together for superior detection of risk versus either test alone.4,5

 

Test Interpretation Guides

Physician working at computer

See our guides for details on test selection, utilization, and interpretation. All information is based on peer-reviewed publications and practice guidelines.

 

References
  1. American College of Obstetricians and Gynecologists. Practice advisory: cervical cancer screening (update). https://www.acog.org/Clinical-Guidance-and-Publications/Practice-Advisories/Practice-Advisory-Cervical-Cancer-Screening-Update?IsMobileSet=false. Published August 21, 2018. Accessed May 17, 2019.
  2. US Preventive Services Task Force. Final recommendation statement. Cervical cancer: screening. https://www. uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/cervical-cancer-screening2. Updated August 2018. Accessed May 17, 2019.
  3. Saslow D, Solomon D, Lawson HW, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin. 2012;62(3):147-172. doi: 10.3322/caac.21139
  4. Blatt AJ, Kennedy R, Luff RD, Austin RM, Rabin DS. Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices. Cancer Cytopathol. 2015;123:282-288. doi: 10.1002/cncy.21544
  5. Quest Diagnostics. Data on file. 2015